Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas T MacDonald

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Cytokine & Growth Factor Reviews|July 8, 2010
Interleukin-25: a two-edged sword in the control of immune-inflammatory responsesGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Journal of Inflammation (London, England)|May 5, 2011
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune systemAnna Vossenkämper, Thomas T Macdonald, Olivier Marchès
Trends in Pharmacological Sciences|July 21, 2009
Interleukin-21 as a new therapeutic target for immune-mediated diseasesGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Biochemical Society Transactions|July 27, 2011
The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel diseaseThomas T MacDonald, Iona Bell, Giovanni Monteleone
The British Journal of Nutrition|January 27, 2010
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studiesJenny Epstein, Ian R Sanderson, Thomas T Macdonald
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Frontiers in Medicine|August 22, 2017
The Role of Cytokines in the Fibrotic Responses in Crohn's DiseaseRenata Curciarello, Guillermo H Docena, Thomas T MacDonald
Current Opinion in Gastroenterology|March 28, 2012
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesisIvan Monteleone, Thomas T MacDonald, Francesco Pallone, et al.
Inflammatory Bowel Diseases|April 18, 2012
What's the next best cytokine target in IBD?Thomas T MacDonald, Paolo Biancheri, Massimiliano Sarra, et al.
Inflammatory Bowel Diseases|March 12, 2010
IL-23/IL-17 axis in IBDMassimiliano Sarra, Francesco Pallone, Thomas T Macdonald, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Cytokine & Growth Factor Reviews|July 8, 2010
Interleukin-25: a two-edged sword in the control of immune-inflammatory responsesGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Journal of Inflammation (London, England)|May 5, 2011
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune systemAnna Vossenkämper, Thomas T Macdonald, Olivier Marchès
Trends in Pharmacological Sciences|July 21, 2009
Interleukin-21 as a new therapeutic target for immune-mediated diseasesGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Biochemical Society Transactions|July 27, 2011
The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel diseaseThomas T MacDonald, Iona Bell, Giovanni Monteleone
The British Journal of Nutrition|January 27, 2010
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studiesJenny Epstein, Ian R Sanderson, Thomas T Macdonald
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Frontiers in Medicine|August 22, 2017
The Role of Cytokines in the Fibrotic Responses in Crohn's DiseaseRenata Curciarello, Guillermo H Docena, Thomas T MacDonald
Current Opinion in Gastroenterology|March 28, 2012
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesisIvan Monteleone, Thomas T MacDonald, Francesco Pallone, et al.
Inflammatory Bowel Diseases|April 18, 2012
What's the next best cytokine target in IBD?Thomas T MacDonald, Paolo Biancheri, Massimiliano Sarra, et al.
Inflammatory Bowel Diseases|March 12, 2010
IL-23/IL-17 axis in IBDMassimiliano Sarra, Francesco Pallone, Thomas T Macdonald, et al.
Pageof 15